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During the past decade, it has become apparent that much of the sequence
diversity of antibodies results from the combinatorial rearrangement ofa series
of small genetic elements (reviewed in reference 1) that together comprise the
heavy and light chain variable (V) regions. Additional diversity is generated
during the rearrangement of these genes through junctional diversity (1) and
the generation ofN sequences that are not present in the germline (2) . Studies
of families ofmAbs derived from single germline V regions, and in some cases
from oneB cell precursor, have shown that somatic diversification (3) ofalready
rearranged and expressed Ig V region genes significantly expands the antibody
repertoire (3-9). Theaminoacid alterations that result from thesediversification
events can result in increases or decreases of antibody affinity (4, 5, 10) as well
as changes in antigen specificity (6, 11) .
Initially it was thought that hypermutation was solely responsible for somatic
diversification of mAbs encoded by known germline genes (3-9) . However,
recently questions have been raised concerning other genetic mechanisms that
may be involved in diversification (12-15), as well as the actual number of
germline V region genes in the genome (16) . These studies have implicated not
only somatic point mutation but also V region replacement (12-14) and gene
conversion (15) in Ig gene diversification . V region replacement has been
demonstrated in vitro (12-14) and involves the replacement of the rearranged
V region by an upstream V region . The second proposed mechanism, gene
conversion occurs in vivo in chicken X light chain where a series of pseudogenes
donate sequences to a single rearranged V region gene (15) and has been
suggested as the mechanism that generated a variable region mutation in vitro
in a hybridoma cell line (17) .
Although extensive studies of families of mAbs (3-9) suggest that sequence
diversification arises through somatic point mutation, this has not been formally
proven . In fact, since the base changes that are observed sometimes appear to
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be clustered (8) and include substitutions of two or even three bases in a codon
(5, 18-20), it is possible that either donor sequences or previously unidentified
germline V region genes could account for the sequence differences found .
To directly address the issue of the genetic mechanisms involved in antibody
diversity, we have examined two selected hybridomas which arose during the
antiphosphorylcholine (PC)' response in BALB/c mice . The response of BALB/c
mice to PC, either associated with bacterial polysaccharides or coupled to protein
carriers, has been extremely well studied (21) . Almost all of the antibodies
produced are encoded by theV1 gene of the S107 (T15) heavy chainV region
family in association with any one of three light chains (21, 22) . All of the T15
IgM anti-PC antibodies so far reported in the literature have the germline V.1,
DFL 16.1, and JH1 sequences, while all of the IgG antibodies have numerous
base substitutions (8, 19, 21) . Mice that have been idiotypically suppressed (24,
25) or have genetic defects in their immune response (CBA/N) may express
other heavy or light chain V regions (26) .
We selected an IgM and an IgG2a anti-PC antibody for detailed study since
they were likely to represent earlier and later stages in somatic diversification .
Since most anti-PC IgMs have not undergone any somatic diversification (8), we
screened 60 IgM anti-PC antibodies for loss of reactivity with a battery of anti-
T15 antiidiotypic mAbs and identified one, P28, which had lost reactivity with
a heavy chain-specific antibody (27) . The IgG2a antibody, RP93, was isolated
from a hyperimmunized mouse and had also lost reactivity with the same anti-
heavy chain, antiidiotypic antibody, and in addition, no longer reacted with
another antiidiotypic antibody that required the presence of theT15 light chain
(27) . The nucleic acid sequences of the heavy and light chain variable regions
and the adjoining constant region domains were determined. Oligonucleotides
specific for sequences that included the two base pair changes in the second
hypervariable region of each of the heavy chains were then used to look for
other V regions or potential donor sequences in the germline . Our results
indicate that the base changes examined arose through somatic point mutation
rather than through gene conversion, V region replacement, or the expression
of previously undiscovered germline genes . We have also examined the impact
of the sequence changes on the serology of the binding site .
Materials and Methods
Cell Lines and Cell Culture Conditions.
￿
The 5107.3.4 (S 107) myeloma cell line was
originally obtained from the Salk Institute cell bank.The P28 hybridoma cell line was
isolated from a BALB/c mouse initially immunized with 200 Ag of PC conjugated to
keyhole limpet hemocyanin (PC-KLH) emulsified in CFA (27) . After 3 mo the mice were
boosted with 200 tag of PC coupled to LPS and 3 d later the spleen cells were fused . The
RP93 hybridoma cell line was isolated from a BALB/c mouse hyperimmunized with
multiple injections of 250 kg PC-KLH emulsified in CFA and IFA. Two control PC
binding mAbs were also used . PC-140 is an IgM T15 PC binding mAb that has been
described previously (28) . 8A1-G2a is an IgG2a PC-binding T15 mAb that was derived
by in vitro heavy chain class switching from PC-223 . W3129 is a dextran-binding IgA
myeloma protein kindly provided by Dr . Sherie Morrison (Columbia University, New
York, NY). All ofthemyelomaandhybridoma cell lines were maintained in an atmosphere
'Abbreviations used in this paper :
￿
C, choline ; HV, hypervariable region ; KLH, keyhole limpet
hemocyanin ; NPPC, nitrophenylphosphorylcholine ; PC, phosphorylcholine .956
￿
DIVERSIFICATION OF ANTIPHOSPHORYLCHOLINE ANTIBODIES
of 8% C02 at 37°C in DME (Gibco Laboratories, Grand Island, NY) and supplemented
with 10% FCS, 5% NCTC 109 (Gibco Laboratories), nonessential aminoacids, glutamine,
penicillin, and streptomycin (29).
Purification ofS107, P28, PC-140, and RP93 Proteins.
￿
Ascites fluid containing hybrid-
omaproteins was obtained by injecting 10' exponentially growingcellsinto theperitoneal
cavity of Pristane-primed (30) BALB/c mice. The hybridomaprotein accumulated in the
ascites fluid at 3-10 mg per ml. The PC binding proteins were purified by affinity
chromatography over a PC-tyrosine-glycyl-Sepharose 4B column (31, 32). The bound
antibodies were eluted with PC and the eluates were subsequently dialyzed to remove the
hapten.
Serological Analysis.
￿
Direct binding ELISAs were carried out as described previously
(33). The ELISA plates were initially coated with 10 ug/ml of purified PC-140, P28, or
RP93 protein. After blocking with BSA, 50 jul of supernatants containing each of eight
rat anti-T15 antibodies (27) were added. The amount of binding was detected using an
alkaline phosphatase-linked goat anti-rat IgG (Zymed Laboratories, San Francisco, CA).
The final optical density unitswere determined at 405 nm after a 1-h incubation at room
temperature. For inhibition assays, ELISA plates were coated with 100 fd of 1 tcg/m)
purified S107 protein. The binding site-specific mAb, 4C11, was kindly provided by Dr.
Heinz Kohler, Roswell Park, Buffalo, NY (34). Anti-PC bindingsite rabbit antiserumwas
prepared according to Claflin and Davie (31). An amount of anti-binding site antibody
that bound 50% of the sites on the plate was incubated with increasing dilutions of
inhibitor proteins, S107, P28, or RP93 for 1 h at room temperature. 50 A1/well of each
dilution was added to the ELISA plates and incubated for 1 h at 37'C. The amount of
bound 4CI 1 protein was determined using goat anti-mouse IgGI (Zymed Laboratories)
and the rabbit anti-binding site antibody was detected using enzyme-linked goat anti-
rabbit IgG antisera (Zymed Laboratories).
Determination of Fine Specificity.
￿
ELISA plates were coated with 10 P.g/ml PC-BSA.
5107, P223, P28, and RP93 proteins were incubated with increasing concentrations of
PC or oneof two analogues, nitrophenylphosphorycholine (NPPC) or choline (C), for 2 h
at room temperature and then added to the PC-BSA-coated ELISA plate and incubated
for an additional hour at 37°C. The assay was developed using class- or subclass-specific
rabbit anti-mouse enzyme-linked antiserum (Zymed Laboratories)and the optical density
units were determined.
Measurement of Affinity.
￿
The affinity for PC was determined using ultra-high speed
centrifugation in an air-fuge (Beckman Instruments, Inc., Fullerton, CA) (35-37). 2 mg
of purified protein were incubated with "C-labeled PC (New England Nuclear, Boston,
MA) in Tris/NaClbuffer at amolarity 10-fold less than that of the protein. I00 ,ul aliquots
were added to six separate tubes containing increasing amounts of unlabeled PC and to
one control tube containing no cold PC. The tubes were incubated at room temperature
for 30 min and then 200,ul of each sample was centrifuged in 5 x 20 mm polyallomer
tubes for 3 h at 150,000 g (30 psi) at room temperature. The amount of bound "C-PC
was calculated from theamount of free "C-PC.
Reverse Transcriptase Sequencing.
￿
Total RNA from S107, P28, and RP93 cells were
extracted with guanidinium isothiocyanate and isolated over a CsCI gradient (38).
Poly(A)+ mRNA was purified over an oligo-dT-cellulose column according to Maniatis et
al. (39). 20,ug of Poly(A)' mRNA was hybridized to labeled oligonucleotide specific for
the region to be sequenced. Extension reactions were carried out according to Geleibter
et al. (40) using reverse transcriptase in the presence of dNTPs and terminated with
ddNTPs (41).
Probes and Primers.
￿
The location of each of the oligonucleotides used is indicated in
the relevant figures. The S107 and P28 light chain V regions were sequenced using two
oligonucleotides; a 20-bp primer (3' GGTTCGACCTCGACTTTTCAC 5') complemen-
tary to the S107A light chain 3' region of J1, and a second 21-bp oligonucleotide (3'
GCTATGTAACCCCAGGGACTA5')specific forthe middle of the V region. TheRP93
light chain V region was sequenced with the following oligonucleotides: a 16-bp primer
(3' GTAGAAGGGTGGATGG 5') specific for the 5' region of the C, domain, and a 20-CHIEN ET AL .
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by primer (3' GCTAAAAGACCCCAGGGTCT 5') specific for the middle of the RP93
V,, region . The C,, domains of all the antibodies were sequenced with the following two
oligonucleotides : a 21-bp primer (3' AAGTTGTCCTTACTCACAATC 5') specific for
the 3' end of the C,,, and a 21-bp primer (3' AAGATGGGGTTTCTGTAGTT 5')
specific for the middle ofC,
The heavy chain CH 1 domains were sequenced with the following oligonucleotides :
IgM-specific ; a 19-bp primer (3' AGACGTACACGGGTAAGGT 5') complementary to
the 3' end of the CHI, a 20-bp primer (3' GTGACTTCAGTAGGTCCCA 5') specific
for the middle, and a 17-bp primer (3' AGGGGGAGCAGAGGACG 5') specific for the
5' end ; IgA-specific ; 3' end primer (3' TTAACCTACACTTAACGAGAC 5') and middle
primer (3' ATGAAGGGAAAGCCGTGCTAC 5') ; IgG2a-specific 3' end primer (3'
TCGTGGTTCCACCTGTTCTTTTAA 5') and middle primer (3' TGTGGA-
AGGGTCGACAGG 5') and 5' end (3' CAGATAGGTGACCGG 5') . The heavy chain
V region sequences were completed using the following oligonucleotides complementary
to sequences in the middle of the V regions : RP93 (3' TATGTTATCTCATGCCACG
5') ; S107 (3' GTAGACACTTCCCAGCCAAGAAG 5') ; P28 (3' GAAGACACTT-
CCCAGCCAAGAAG 5') .
The oligonucleotides used as probes are specifically defined in the Results section. The
12P nick-translated genomic probes were prepared from a 250-bp Dde I-Dde I fragment
isolated from a plasmid containing a cDNA clone of 5107 VH1 and a 2-kb Bam HI-Eco
RI genomic probe containing theJ3 andJA genes and 3' intervening sequence (42, 43) .
DNA Isolation and Gel Analysis.
￿
High molecular weight DNA was isolated from the
myeloma and hybridoma cells as described by Alt et al . (2) . Approximately 108 cells were
treated with proteinase K and extracted with phenol . The high molecular weight DNA
was precipitated using cold 100% EtOH . Restriction enzyme digests were done and
Southern blotting was performed by electrophoretically fractionating the DNA on an
0 .8% agarose gel in 0.04M Tris-acetate, 0.05M NaOAc, 0 .001 M EDTA . The DNA was
transferred to Genescreen (New England Nuclear) . Molecular hybridizations were done
using procedures from Zeff et al . (44) .
Results
Identification ofVariants .
￿
Our goal was to study the mechanism and impact of
somatic diversification both early and late in the immune response by examining
T 15' anti-PC mAbs derived from PC-immunized BALB/c mice . To identify an
mAb from early in the process of somatic diversification, 60 IgM anti-PC
antibody-producing hybrids were screened using 8 different anti-T 15 antibodies
(27) . Only one of the 60 IgM anti-PC-producing hybridomas, P28, was found
to have altered serology when compared with the germline represented by the
mAb PC-140 and the prototype S107 antibodies (27) . In addition, one IgG2a
anti-PC-producing hybridoma, RP93, from a hyperimmunized mouse also did
not react with the same antiidiotypic mAb . Fig . 1 illustrates the binding results
of the P28, RP93, and PC-140 proteins using five of the eight anti-T15 antibod-
ies . As can be seen, both the P28 and RP93 proteins do not react with the
antiidiotype antibody TC54 while PC-140 reacted with all of the antiidiotypic
antibodies . In addition to the loss of TC54 reactivity, the RP93 protein also did
not react with a second antiidiotype, TC 139 . It has been shown previously that
the TC54 antibody is specific for the V region of the heavy chain (V ) while the
TC 139 antibody requires the presence of both the T15 heavy and light chains
(27) . The results indicate that both the P28 and RP93 antibodies possess the
dominantT 15 heavy chain idiotype because theywere recognized by the majority
of the anti-T 15 antibodies and because both antibodies bind PC . The loss of
TC54 reactivity, however, suggested thatboth the P28 and RP93 antibodies had958
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FIGURE 1 .
￿
Direct bindingELISA of rat anti-T15 mAbs TC68,
TC156, TC38, TC54, andTC139 to 10 tag/ml of PC-140, P28,
and RP93 protein absorbed to ELISA plates . Binding of the rat
antibodies was detected with a goat anti-rat Ig antibody conju-
gated with alkaline phosphatase . The amount of binding is
represented in OD*oa . TC68, TC156, TC38, and TC54 are
heavy chain specific and TC139 requires both theT15 light and
heavy chain . (/) PC-140, (®) P28.9, (p) RP93 .
undergone diversification oftheirV regions, resulting in the loss ofthe idiotope .
In addition, the loss ofTC139 reactivity by the RP93 protein suggested that the
T15 light chain was either not present or had undergone diversification in RP93 .
RNA Sequencing. To determine the structural changes associated with the
somatic diversification, the nucleic acid sequences of both the heavy and light
chains of the P28 and RP93 antibodies were determined by reverse transcriptase
sequencing of poly(A)' RNA. TheV, D,J., and the adjoiningCH1 domains of
the heavy chains and the VK , JK, and CK domains of the light chains were
sequenced (Figs . 2-4) . The remaining domains of the heavy chain constant
regions were not sequenced because SDS-PAGE gel analysis of both P28 and
RP93 proteins did not reveal any major domain losses (data not shown) . The
sequences of the heavy and light chain of the P28 mRNA and the heavy chain
of the RP93 mRNA were determined simultaneously with and compared with
the sequence of the anti-PC antibody 5107 . This was done because the S107
antibody is known to be encoded by the rearranged T15 V1 DFL 16 .1 andJH1
germline genes and thus provided a germline control on each sequencing gel
(45) .
Fig. 2 shows the nucleic acid and translated amino acid heavy chain sequence
of the IgM P28 antibody compared with the S107 antibody. There were two
base pair differences in and just 3' to the second hypervariable (HV2) region
and one in the JH region (as shown by the bold lettering) . The only exchange
substitution was the one just 3' of the HV2 at residue 71 which resulted in an
isoleucine being substituted by a phenylalanine . None of these base changes
appear in the other members of the S107 (T15) heavy chain variable region
family or in any other published hybridomas derived from the V1 gene (21) .
The CHI domain did not differ from the IgM germline sequence (46, 47) . The
light chainVK, JK, and CK regions of the P28 antibody were also sequenced and
were identical to the VK22 JK5 germline sequence of the expressed S107A light
chain (48) (data not shown) . It was concluded that the P28 antibody had
undergone somatic diversification and that the loss of TC54 reactivity by the
P28 antibody was due solely to the altered amino acid at residue 71 in the V
region .
The heavy and light chains of the IgG2a RP93 antibody were then sequenced
to determine the degree of somatic diversification . The sequences of the heavy
chain are shown in Fig. 3 . There are 9 by substitutions in the V region ofRP93CHIEN ET AL .
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FIGURE 2 .
￿
Nucleotide sequence and translated amino acid sequence of the heavy chain V,
D, J, and CHI regions of the P28 antibody compared with the S107 antibody. For the V
region, the dashed lines indicate homologous sequence, and in the CHI region the dashed
lines represent identity with the germline constant region sequence . Residues containing single
base pair differences are indicated in bold lettering. The oligonucleotides used for priming
are represented by the slashed bars except for the two upper bars in HV2, which represent
oligonucleotides used only as probes. These sequence data have been submitted to the
EMBL/GenBank Data Libraries under accession number Y00650 .
when compared with the germline V.1 as expressed in S107 . 6 of the 9 by
changes result in amino acid substitutions . In addition, RP93 has a junctional
change in the 3' codon ofV.1, which also results in an amino acid change . None
of these base changes are present in the germline genes of other members of the
T15 VH gene family or in the published sequences of other relevant mAbs (21) .
Starting with the base change and amino acid substitution at the VDjunction,
the sequences of S107 and RP93 diverge . RP93 does not use the same D as
5107 . The sequences between the V and J in RP93 do not correspond to a
known D and could represent either an unreported D, N sequences, or some
combination ofthese . In addition, RP93 uses J,,4 rather than J,t 1 and has deleted
the first 3 codons of the germline JH4 sequence (Fig. 3) (43, 44) . The remainder
of J4 is germline in sequence and the C 1 domain of RP93 is identical to the960
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FIGURE 3 .
￿
Nucleic acid sequence and translated amino acid sequence of the heavy chain V,
D, J, and CHI regions of the RP93 antibody compared with the S107 antibody . In the V
region, the sequence homologies are indicated by the dashed lines and in the CH 1 domain the
dashed lines represent identity with the germline constant region sequence . The base pair and
amino acid differences are indicated in bold lettering . The oligonucleotide primers used for
determining the nucleotide sequences are illustrated by the slashed boxes .
published IgG germline sequences of this domain (49) . None of the base pair
changes oramino acid substitutions in RP93 coincide with the changes found in
the P28 heavy chain sequence so loss of binding to TC54 in RP93 must be due
to a conformational change in the TC54 epitope .
The light chain of the RP93 antibody was also sequenced (Fig . 4) and it shared
only 50% homology with the S107VK region . However, the sequence was found
to be highly homologous to theNH2-terminal 43 residues that had been reported
for a T15 anti-PC antibody, 1B8E5, isolated from a CBA/N mouse (26) . The
homologous residues are indicated by the dashes . In addition to the nonhomo-
logous VK regions, the RP93 light chain was found to use theJK1 region rather
than the JK5, which is used by the S107A light chain (48) . The CK domain,
however, was found to be completely homologous with the germline sequence
(50, 51) . The lack of binding of TC139 andidiotypic antibody (Fig . 1), which
requires the presence of the T15 light chain, is thus explained .CHIEN ET AL .
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FIGURE 4 .
￿
Nucleic acid sequence and translated amino acid sequence of the V, J, and C
genes encoding the light chains ofthe RP93 antibody compared with the NH2-terminal amino
acid sequence of the anti-PC antibody, IB8E5, isolated by Clarke and colleagues from a
CBA/N mouse (26) . The oligonucleotide primers used for determining the nucleotide se-
quence are indicated by the slashed boxes .
Identification of Genetic Mechanisms.
￿
DNA isolated from the P28, RP93, and
S107 cell lines and BALB/c liver was examined with mutant and wild-type
oligonucleotides and a variety of restriction enzymes in an attempt to determine
the genetic mechanisms responsible for the base pair changes represented in
both the P28 and RP93 antibodies . In Fig . 5, high molecular weight DNA from
S107, P28, and BALB/c liver cells was digested with Eco RI and the fragments
resolved on an 0.8% agarose gel. Fig. 5A shows a blot hybridized under stringent
conditions with an oligonucleotide (Fig . 2, lower slashed bar over HV2) specific
for the 2 by changes in and around theHV2 region in the P28 heavy chain . We
chose these twobase pair changes because they were closely linked and therefore
were good candidates for a donor sequence or an unidentified V gene . The
results revealed a single 7.8-kb fragment present only in the P28 sample and not962
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FIGURE 5 .
￿
Southern blot analysis ofS107,
P28, and BALB/c liver DNA samples . The
DNA was digested with Eco RI and the
fragments were resolved by agarose gel elec-
trophoresis . The blot represented in A was
hybridized under stringent conditions using
a P28-specific oligonucleotide that included
the two A-T substitutions in and just 3' to
HV2 (Fig. 2). (B) The same blot stripped
andrehybridizedunderstringent conditions
with a T15 V 1 gene-specific genomic
probe (see text for details) . The 2.8- and
3.4-kb fragments always hybridize less well
with this probe .
in either the S107 or genomic (liver) DNA samples . To ensure that the P28
specific oligonucleotide was recognizing the rearranged V 1 gene in addition to
being P28 specific, the blot shown in A was stripped and rehybridized with a
T15 V,,1-specific genome probe . In Fig. 5B, it can be seen that the probe
identified the four major fragments reported by Crews et al . (45) that represent
the four well-characterized members of the T15 V,, gene family . It is known that
the slowest migrating fragment (7.8 kb) represents the unrearranged T15 V,,1
gene and that the migration of this fragment is not affected by VDJ re-
arrangement in the S107 cell line (45) . Other crosshybridizing bands, such as
the 3.6-kb fragment in the BALB/c liver sample, frequently appear in such blots
(45) . The fragment identified by the P28-specific oligonucleotide was found to
comigrate with the expressed VH1 gene identified in the 5107 sample . The
presence of the hybridizing bands in the 5107 and BALB/c liver DNA samples
indicated that there was DNA present in all the lanes, thereby confirming that
the P28-specific oligonucleotide was reacting only with P28 DNA.
Failure to identify any other hybridizing bands in the genomic DNA sample
using the P28-specific oligonucleotide suggested the absence of any donor
sequences or any P28-like germline VH gene ; thus making it unlikely that gene
conversion or V region replacement were mechanisms responsible for the base
pair changes found in the P28 antibody . To further rule out these mechanisms,
two additional sets of experiments were done . The first experiment dealt with
the possibility that the Eco RI digestion might not reveal a potential donorCHIEN ET AL .
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FIGURE 6.
￿
Southern blot analysis of 5107, RP93, and BALB/c liver DNA samples digested
with Pst I and Hind III and the fragments resolved by agarose gel electrophoresis . (A) Blots
hybridized with a RP93-specific oligonucleotide (Fig . 3) under stringent conditions ; (B) These
blots were then stripped and rehybridized under stringent conditions with an oligonucleotide
specific for the HV I region and its immediate flanking sequences which are not changed in
RP93 .
sequence and involved the digestion of theDNA with two additional restriction
enzymes, Pst I and Hind 111, and hybridization of the blots with the same probes
described above (data not shown) . In the second experiment, the DNA was
digested with Eco RI and then hybridized to oligonucleotides synthesized to the
individual base pair changes (upper slashed bars in Fig . 2) in and around the
second hypervariable region on the chance that one of the base pair changes
arose through somatic point mutation while the other was present in a potential
donor sequence (data not shown) . Both sets of experiments failed to reveal either
a potential donor sequence or a P28-like germline gene, verifying thedata shown
in Fig . 5 . Therefore, we concluded that somatic point mutation is the most likely
mechanism responsible for the base pair changes in the P28 variant antibody .
Mutant-specific oligonucleotides were also used to examine the genetic mech-
anism responsible for the two base pair changes in the second hypervariable
region of the RP93 heavy chain (see Fig . 3) . Various restriction digests were
probed with the 20-base oligonucleotide represented by the slashed bar in Fig .
3 . The Pst 1 and Hind III digests are shown in Fig. 6. When DNA is digested
with Pst I and Hind III and hybridized with the RP93-specific oligonucleotide
under stringent conditions, only DNA from the RP93 cell line hybridized with
the oligonucleotide, revealing a 3 .2- (Pst 1) and a 6.6-kb (Hind 111) fragment,
respectively (Fig . 6A) . No hybridizing bands were found in the S107 or BALB/c
liver DNA samples. The data suggest that, similar to the changes in the P28964
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antibody, the linked base pair changes in the HV2 region of the RP93 antibody
most likely arose through somatic point mutation rather than from a donor or
RP93-like VH gene sequences in the genomic DNA. To confirm that the frag-
ments identified in panel A also represented the rearranged and expressed T15
V1 gene, the blots were stripped and rehybridized with an oligonucleotide that
was complementary to the unmutated sequences in the HV1 region of V1 in
the S107, RP93, and BALB/c liver DNA. The results are shown in Fig. 6B,
where it can be seen that the identical rearranged 3.2- and 6.6-kb bands seen in
A also hybridized. Similar blots were hybridized with aJH-specific genomic probe
and confirmed that the 3.2- and 6.6-kb fragments represented the rearranged
genes in 5107 and RP93, respectively (data not shown). The differences in size
between the hybridizing bands found in the S107 and RP93 samples (Fig. 6B)
are fully accounted for by the location ofthe Pst I and Hind III sites located 3'
to the J1 and JA regions. The absence of an unrearranged germline VH1 in
S107 is due to the deletion of the T15 family on the other allele, presumably
during an aberrant rearrangement that preceded the myc into the a switch site.
The lack ofa germline rearrangement of VH1 in RP93 is assumed to be due to
segregation during the propagation of the hybridoma.
Since the substitution ofAfor Gjust 3' to the HV2 region (see Fig. 3) created
a new Taq I site, we were able to also use Taq I digestion and hybridization with
a genomic VH1 probe (52) to confirm that the mutant gene encoding RP93
replacedthe wild-type VH1 gene, i.e., that the RP93 heavychain was not encoded
by a previously undescribed VH1-like gene (data not shown).
Antigen Binding Analysis.
￿
It is generally accepted that during the course of
the immune response somatic diversification and subsequent selection by antigen
result in the expression of antibodies with progressively higher affinity. To
examine the impact of the one amino acid substitution in the P28 antibody and
the multiple changes and the unusual D,J, and light chain in the RP93 antibody,
we compared the specificity and affinity of these two antibodies with the S107
antibody and with IgM and IgG antibodies that had not undergone somatic
diversification. The specificity of the antibodies was initially compared by deter-
mining their ability to bind the putative natural antigen, pneumococcal C
polysaccharide. The P28 antibody bound as well to the antigen as the germline-
encoded IgM antibody. The binding of the RP93 antibody was compared with
an IgG2a anti-PC antibody that had been generated in vitro by class switching
from an IgM-producing hybridoma and is known to be encoded by the T15
heavy and light chain V regions (33). While the control IgG2a antibody had
easily detectable binding to pneumococcal C polysaccharide at an antibody
concentration of 1 wg/ml, RP93 did not show any binding even at 100 Ag/ml.
The fine specificity of the P28 and RP93 antibodies was compared with that
of S107 and a germline-encoded IgM antibody, P223, in an inhibition ELISA
using PC and two of its analogues, NPPC and choline. The results using S107
and P223 protein represent the usual fine specificity patterns for germline T15
antibodies, i.e., PC inhibits more effectively than NPPC, which is more effective
than choline (Fig. 7). The fine specificity pattern for the P28 protein is shown in
Fig. 7C. It can be seen that the order ofbinding ofPC and choline is similar to
that found with the S107 and P223 proteins. NPPC, however, was barely0
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FIGURE 7 .
￿
Competition inhibition ELISAs of 5107, P223, P28, and RP93 proteins to 10
mg/ml PC-BSA in the presence of increasing concentrations of three haptens, PC (0), NPPC
(A)and choline (0) . The amount of protein bindingwasdetermined with goat anti-mouse Ig
conjugated to alkaline phosphatase and is represented in OD,a5. (A-D) The results from a
single assay using S107, P223, P28, and RP93 proteins, respectively .
distinguishable from choline. This has been a reproducible finding . In contrast
to the other antibodies, the RP93 antibody required less (10-5 M) NPPC for
50% inhibition, while the concentration at which PC inhibited was 10 times
higher. The difference in binding is not due to the y2a constant region since in
other studies (Spira, G., et al ., manuscript submitted for publication) we have
shown that P223 and an IgG2a antibody derived from it by in vitro switching
have the same fine specificity . Therefore, RP93 clearly possesses an altered fine
specificity .
Affinity data confirmed theabove binding results . When P28, RP93, and 5107
proteins were examined, theirKa values were as follows : S107 = 3.4 x 105/M ;
P28= 2.5 x 105/M ; and RP93 = 1 .6 x 105/M . TheKa value ofS107 represents
the germline affinity of T15 anti-PC antibodies . The Ka value of the RP93
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FIGURE 8.
￿
Competition inhibition ELISA of the anti-
T15 binding site-specific monoclonal 4C11 to S107-
coated ELISA plates in the presence of 5107, P28, and
RP93 protein. Increasing concentrations ofinhibitor pro-
tein were added and the binding of 4CII to S107 de-
tected with a goat anti-mouse IgGI conjugated to alka-
line phosphatase. The amount of 4C 11 used was com-
pletely inhibitable with PC (/). The plotted values are
shown with the background subtracted and represented
in ODaos-
antibody for PC was found to be lower than that of the 5107 protein, while the
value for the P28 antibody was in between. The affinity values for S107 have
been determined in our laboratory on numerous occasions. The values were
found to be in the range of 2.2-3 .3 X 105/M, so we believe that the difference
between S107 and RP93 represents a real decrease in affinity for PC. The lower
affinity value of RP93 for PC coincides well with the fine specificity results,
which show a preferred binding to NPPC rather than PC by the RP93 antibody.
Binding Site Analysis.
￿
The altered affinity and specificity of RP93, and perhaps
of P28 antibodies suggested a change in the conformation of the binding site of
both of the proteins. To confirm that the binding sites had undergone significant
conformational changes, both proteins were tested with a binding site-specific
mAb (4C11) and a binding site-specific polyclonal antiserum by inhibition
ELISA. Fig. 8 shows the reactivity of S107, P28, and RP93 proteins with the
andidiotypic mAb 4C 11 . The 4C 11 antibody was shown to be binding site
specific under the conditions used because it was completely inhibitable by PC
(indicated by the black box). Both the S107 and P28 proteins efficiently inhibited
the binding of 4C I I to S107, while the RP93 protein did not. However, an -60-
fold higher concentration of P28 protein than S107 protein was required to
inhibit, suggesting a difference in the binding sites of the P28 and S 107 proteins.
Similar results were obtained when the polyclonal anti-binding site-specific
antiserum was used (data not shown).
These results, taken together with the fine specificity and affinity data, suggest
that the binding site of the P28 antibody has undergone a minor conformational
change due to the single amino acid substitution at residue 68, while the binding
site of the RP93 antibody has undergone a major conformational change due to
its aminoacid substitutions, its unusual D, J, and light chain, or some combination
of these.
Discussion
The analysis of large numbers of mAbs has led to the conclusion that point
mutations are primarily responsible for the somatic diversification of already
rearranged and expressed V region genes that occurs during the immune
response (3-9, 18-21). Three recent findings, however, have raised importantCHIEN ET AL.
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questions about this interpretation of the results . Gene conversion has been
shown to play a major role in creation of the X light chain repertoire in chickens
(15) ; V region replacement has been shown to occur in vitro (12-14) ; and data
have again been presented suggesting that the germline VH region repertoire
may be much larger than had been predicted from other studies (16) . These
findings make it important to formally examine the genetic and molecular
mechanisms responsible for the base changes that appear during the immune
response . While it is not a simple matter to establish the mechanism responsible
for each base change, we have attempted to do this for a few of the changes we
have observed in two mAbs that are presumed to arise from the VH1 gene of the
S107 (T15) family . We picked this system because the S107 (T15) VH region
family is small and very well studied . Since it has been well documented that
most T 15 IgM antibodies have not undergone somatic diversification (8), we had
to screen 60 such monoclonals with antiidiotypic antibodies to find one that
appeared to have undergone somatic diversification . Based on its class, the fact
that it is the firstT 15 IgM PC binding monoclonal to differ in its sequence from
the germline, and the absence of base pair changes in the light chain, we have
made the assumption that it represents an early stage of somatic diversification .
We chose an IgG2a PC binding antibody expressing the VH1 gene from a
hyperimmunized animal to represent a later stage in somatic diversification .
Since IgG2a antibodies containing the T15 (VK22) light chain are not observed
in vivo or found in mAbs (21, 53), it is not surprising that the RP93 antibody
possesses a different light chain .
Although we cannot prove that these antibodies represent different stages in
the immune response, their sequences and characteristics of the antibody suggest
that this is true . For example, the larger number of base pair changes in the
RP93 antibody is consistent with this assumption . Other properties of the RP93
antibody also suggest that it is a late product of the immune response . The
animal from which it was derived had been hyperimmunized with PC-KLH .
NPPC more closely represents the linkage group that results when PC is attached
to a protein carrier and is probably a better reflection of the epitope that drove
the secondary response than PC . This could explain why RP93 reacts better with
NPPC than PC and in fact has a lower affinity for PC than 5107 . On the other
hand, RP93 is still readily inhibitable by PC so it does not fall into the group II
PC binding antibodies that arise during the secondary response (53) .
If the base pair change differences we observed in both the P28 and RP93
antibodies were due to the expression of previously unidentified VH1-like germ-
line genes, gene conversion from an as-yet-unreported donor, or V region
replacement, then closely linked base changes provide the best way to find the
responsible genetic material . We have therefore used mutant-specific oligonucle-
otides to look for such sequences in the germline . Our inability to find such
donor sequences strongly suggests to us that the P28 and RP93 antibodies were
not derived from germline V region genes other than VH 1 either by the direct
expression of such genes or through V region replacement .
It is more difficult to formally rule out gene conversion . It is possible that a
donor sequence might have been either too large or too small to be detected in
our gels. This seems unlikely since we have used a variety of restriction enzymes968
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to digest the liver DNA. It is also possible that one of the two base changes
examined was present in the germline and the other arose through point
mutation. We have ruled this out for P28 by examining each of the base changes
individually. Finally, it is possible that the putative donor sequence is smaller
than the oligonucleotide used and differs from it in its immediate flanking
sequences. Since the P28-specific oligonucleotide we used goes beyond the base
changes by only a few bases at each end (see Fig. 2), this also seems unlikely.
Furthermore, the data in the literature suggest that gene conversion requires a
donor of at least 24 nucleotides (54). However, since oligonucleotides of at least
15 bp, and in our case, often 18 or 20 bp, are required to obtain good
hybridization, we cannot completely rule out multiple very small donorsequences
acting sequentially. Nevertheless, we believe that the data presented here strongly
support somatic point mutation as the genetic mechanism responsible for those
base changes examined.
Each of the monoclonals examined was also inherently interesting. P28 is, to
our knowledge, the first PC-binding IgM antibody reported to have undergone
somatic mutation. It confirms the conclusions from other systems (4, 55) that
class switching is not required for somatic diversification. It is also of interest to
note that despite the many somatic mutations in the RP93 V region, there are
no base changes in the C region. This result provides additional support for the
widely held, though only moderately well documented (1, 7, 9, 18) view, that
somatic mutation is restricted to the V region and its immediate flanking
sequences in vivo. The small changes in affinity, fine specificity (similarity with
NPPC and choline), and reactivity with antiidiotypic antibodies in P28 suggest
that the single amino acid substitution not only caused the complete loss of
reactivity with a non-binding site-specific andidiotypic antibody (TC54) but also
resulted in a minor but significant change in the structure of its binding site.
This is consistent with the finding from three-dimensional studies of protein
antigen-antibody interaction (56) that residues outside of the previously defined
hypervariable regions may affect antigen binding. It is also worth noting that
TC54 has been used in the literature (53, 57-59) to identify T15 antibodies and
this shows that the epitope it reacts with can be lost while PC binding is retained.
While we had hoped that the P28 and RP93 antibodies would share some
sequence differences and allow us to locate the TC54 epitope, this is clearly'not
possible since RP93 is a very unusual antibody. Despite the fact that RP93 uses
the V.1 gene, still binds PC, and reacts with many of the anti-T15 mAbs, it
differs from S107 and P28 by a number of amino acids in V and in the third
complementarity determining region of the H chain. In addition, it uses a
different heavy chain J region and contains a light chain that is very different
from the VK22 light chain found in S107. Light chains ofthis same VK3 subgroup
have also been reported (60) in type II PC binding antibodies that do not use
V 1, are not inhibitable by PC (53) but are by NPPC, and do not express the
T 15 idiotype. Type II antibodies are frequently found in the secondary response
to PC-KLH (53). In addition, a light chain that is very homologous to that of
RP93 was also found in a PC binding antibody from a CBA/N mouse (26).
CBA/N mice have an xid immunological deficiency gene that results in anCHIEN ET AL .
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inability to make T15 anti-PC antibodies or to produce many other antipolysac-
charide antibodies .
It is interesting to speculate on theoriginsof the RP93 antibody . It wasderived
from a mouse that had been repeatedly injected with PC-KLH in Freund's
adjuvant . RP93 may have been derived from a B cell clone that originally did
not react with PC on bacterial polysaccharides or perhaps even NPPC, but as a
result of somatic diversification, acquired binding for both PC and NPPC and
was then stimulated to proliferate and perhaps further diversify. While it is not
possible to trace the origins of RP93, it does represent the kind of antibody
discussed by Milsteinand hiscolleagues (4, 18), which differfrom thoseexpressed
early in the immune response and are brought into the immune response as it
progresses .
Summary
The genetic mechanism responsible for the somatic diversification of two
mAbs was determined . The two PC-binding hybridomas were representative of
events early and late in the immune response . The P28 cell line that produces
an IgM antibody and thus represents events early in the immune response, was
found to have 3 by changes in its heavy chain variable (V) region, with some
changes in antibody affinity or specificity. The RP93 cell line that produces an
IgG2a antibody and thus represents later events in the immune response, was
found to have 9 by changes in its V region resulting in decreased affinity for
PC and altered specificity . Oligonucleotides specific for linked base changes in
the second hypervariable regions of both of these antibodies were used to look
for previously undescribedV regions or other donor sequences that could have
been responsible for these base changes . Since no donor sequences were found,
we have concluded that somatic point mutation rather than gene conversion, V
region replacement or the expression of an unidentified germline V region
gene is truly responsible for at least some of the somatic diversification of these
antibodies .
We thank Terry Kelly for her expert technical assistance, Dr. Terry Potter for helpful
scientific discussions, and Rosalie Spata for her help in preparing the manuscript .
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